Try our beta test site

iCAT for Recurrent/Refractory/HR Solid Tumors

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Katherine Janeway, MD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01853345
First received: April 25, 2013
Last updated: February 9, 2015
Last verified: February 2015